Clinical Trial Update: Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of pomalidomide and nivolumab in people with virus-associated malignancies, including Kaposi sarcoma and EBV/KSHV-assoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv Kshv-associated Lymphomas
• Kaposi Sarcoma

Drugs mentioned

• OPDIVO (nivolumab)
• Pomalyst (pomalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Viral Associated Malignancies, Kaposi Sarcoma | Phase 1 | Status: RECRUITING